[HTML][HTML] Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis

J Yu, Y Zhang, LH Leung, L Liu, F Yang… - Journal of hematology & …, 2016 - Springer
Monoclonal antibodies and small molecule tyrosine kinase inhibitors (TKIs) directed against
the vascular endothelial growth factor (VEGF) or its receptors have been investigated in …

[HTML][HTML] Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis

J Yu, Y Zhang, LH Leung, L Liu, F Yang… - Journal of Hematology & …, 2016 - ncbi.nlm.nih.gov
Monoclonal antibodies and small molecule tyrosine kinase inhibitors (TKIs) directed against
the vascular endothelial growth factor (VEGF) or its receptors have been investigated in …

Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis

J Yu, Y Zhang, LH Leung, L Liu, F Yang… - Journal of Hematology & …, 2016 - go.gale.com
Monoclonal antibodies and small molecule tyrosine kinase inhibitors (TKIs) directed against
the vascular endothelial growth factor (VEGF) or its receptors have been investigated in …

Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis

J Yu, Y Zhang, L Lai-Han, L Liu… - Journal of Hematology …, 2016 - search.proquest.com
Monoclonal antibodies and small molecule tyrosine kinase inhibitors (TKIs) directed against
the vascular endothelial growth factor (VEGF) or its receptors have been investigated in …

[PDF][PDF] Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis

J Yu, Y Zhang, LH Leung, L Liu, F Yang, X Yao - 2016 - cyberleninka.org
Monoclonal antibodies and small molecule tyrosine kinase inhibitors (TKIs) directed against
the vascular endothelial growth factor (VEGF) or its receptors have been investigated in …

Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis

J Yu, Y Zhang, LH Leung, L Liu, F Yang… - Journal of Hematology & …, 2016 - infona.pl
Monoclonal antibodies and small molecule tyrosine kinase inhibitors (TKIs) directed against
the vascular endothelial growth factor (VEGF) or its receptors have been investigated in …

Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis.

J Yu, Y Zhang, LH Leung, L Liu, F Yang… - Journal of Hematology & …, 2016 - europepmc.org
Monoclonal antibodies and small molecule tyrosine kinase inhibitors (TKIs) directed against
the vascular endothelial growth factor (VEGF) or its receptors have been investigated in …

[PDF][PDF] Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis

J Yu, Y Zhang, LH Leung, L Liu, F Yang, X Yao - 2016 - core.ac.uk
Monoclonal antibodies and small molecule tyrosine kinase inhibitors (TKIs) directed against
the vascular endothelial growth factor (VEGF) or its receptors have been investigated in …

Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis

J Yu, Y Zhang, LH Leung, L Liu… - … of hematology & …, 2016 - pubmed.ncbi.nlm.nih.gov
Monoclonal antibodies and small molecule tyrosine kinase inhibitors (TKIs) directed against
the vascular endothelial growth factor (VEGF) or its receptors have been investigated in …

Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis.

J Yu, Y Zhang, LH Leung, L Liu… - … of Hematology & …, 2016 - search.ebscohost.com
Monoclonal antibodies and small molecule tyrosine kinase inhibitors (TKIs) directed against
the vascular endothelial growth factor (VEGF) or its receptors have been investigated in …